Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 8:52 PM UTC
| NCT Number | NCT05197270 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | PHASE1 |
| Target Enrollment | 215 participants |
| Active Locations | 24 sites in the US |
| Sponsor | 4D Molecular Therapeutics |
| Last Updated on CT.gov | February 12, 2026 (Feb 12, 2026) |
As of July 19, 2026: Clinical trial NCT05197270 is currently recruiting participants. This phase1 study for macular degeneration is actively seeking new participants at 24 locations across the United States. The study is sponsored by 4D Molecular Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05197270 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05197270 was last updated Feb 12, 2026 (February 12, 2026). HelloStudys verifies this status automatically.